Abstract
GABAA (γ-aminobutyric acidA) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine α1-subunit gene, that α1-type GABAA receptors, which are mainly expressed in cortical areas and thalamus1, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter γ-aminobutyric acid is preserved. α1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABAA receptors found in the limbic system (α2, α5), in monoaminergic neurons (α3) and in motoneurons (α2, α5)1. Thus, benzodiazepine-induced behavioural responses are mediated by specific GABAA receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fritschy,J. M. & Mohler,H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154–194 (1995).
Barnard,E. A. et al. International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
Mohler,H. & Okada,T. Benzodiazepine receptor: demonstration in the central nervous system. Science 198, 849–851 (1977).
Braestrup,C., Albrechtsen,R. & Squires,R. F. High densities of benzodiazepine receptors in human cortical areas. Nature 269, 702–704 (1977).
Wieland,H. A., Lüddens,H. & Seeburg,P. H. A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267, 1426–1429 (1992).
Kleingoor,C., Wieland,H. A., Korpi,E. R., Seeburg,P. H. & Kettenmann,H. Current potentiation by diazepam but not GABA sensitivity is determined by a single histidine residue. Neuroreport 4, 187–190 (1993).
Benson,J. A., Löw,K., Keist,R., Mohler,H. & Rudolph,U. Pharmacology of recombinant γ-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett. 431, 400–404 (1998).
Fritschy, J.-M. et al. Five subtypes of type A γ-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl Acad. Sci. USA 89, 6726–6730 (1992).
Lakso,M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA 93, 5860–5865 (1996).
Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Melchior,C. L. & Allen,P. M. Interaction of pregnanolone and pregnanolone sulfate with ethanol and pentobarbital. Pharmacol. Biochem. Behav. 42, 605–611 (1992).
Beuzen,A. & Belzung,C. Link between emotional memory and anxiety states: a study by principal component analysis. Physiol. Behav. 58, 111–118 (1995).
Vogel,J. R., Beer,B. & Clody,D. E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacology 21, 1–7 (1971).
Bonetti,E. P. et al. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology 78, 8–18 (1982).
Hunkeler,W. et al. Selective antagonists of benzodiazepines. Nature 290, 514–516 (1981).
Bonetti,E. P. et al. Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol. Pharmacol. Biochem. Behav. 31, 733–749 (1988).
Misslin,R., Belzung,C. & Vogel,E. Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behav. Proc. 18, 119–132 (1989).
Lister,R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180–185 (1987).
Acknowledgements
We thank Y. Lang for blastocyst injections, D. Blaser, S. Ganz, H. Pochetti and G. Schmid for animal care, R. Keist and C. Michel for technical assistance and H. Westphal for providing Ella-cre mice. This work was supported by a grant from the Swiss National Science Foundation.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Rudolph, U., Crestani, F., Benke, D. et al. Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes. Nature 401, 796–800 (1999). https://doi.org/10.1038/44579
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/44579
This article is cited by
-
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
Neuropsychopharmacology (2024)
-
Comparison of different weight-based scalars of remimazolam tosylate for anesthesia induction in obese patients: study protocol for a prospective, controlled trial
Trials (2023)
-
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development
CNS Drugs (2023)
-
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options
European Archives of Psychiatry and Clinical Neuroscience (2023)
-
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
CNS Drugs (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
